MYRIAD GENETICS INC — Director's Dealing 2018

Sep 21, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2018-09-19

Reporting Person: LANCHBURY JERRY S (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-09-19	Common Stock	A	50000	$0.0	Acquired	182294	Direct

Footnotes

F1: Consists of performance stock units granted pursuant to the Companys 2010 Employee, Director and Consultant Equity Incentive Plan. Performance stock units initially granted on September 17, 2017, subject to accomplishment of pre-determined financial performance requirements. On September 19, 2018, the Compensation Committee determined the final award amount based on the accomplishment of the applicable financial performance requirements. Each performance stock unit represents a contingent right to receive one share of the Company?s common stock,and vests 25% on September 25, 2018, 25% on September 25, 2019, 25% on September 25, 2020, and 25% on September 25, 2021.